Conduit Pharmaceuticals Stock Today
| CDTTW Stock | 0.02 0.01 43.80% |
PerformanceWeak
| Odds Of DistressAbove Average
|
Conduit Pharmaceuticals is selling for under 0.0174 as of the 26th of February 2025; that is 43.80% up since the beginning of the trading day. The stock's lowest day price was 0.0121. Conduit Pharmaceuticals has over 59 % chance of experiencing financial distress in the next 2 years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 9th of March 2023 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of September 2023 | Category Healthcare | Classification Health Care |
Conduit Pharmaceuticals is entity of United States. It is traded as Stock on NASDAQ exchange. More on Conduit Pharmaceuticals
Moving against Conduit Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Conduit Stock Highlights
| CEO Director | David Tapolczay | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conduit Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Conduit Pharmaceuticals' financial leverage. It provides some insight into what part of Conduit Pharmaceuticals' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Conduit Pharmaceuticals (CDTTW) is traded on NASDAQ Exchange in USA. It is located in 4995 Murphy Canyon Road, San Diego, CA, United States, 92123 and employs 7 people. Conduit Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry.
Conduit Pharmaceuticals generates positive cash flow from operations, but has no cash available
Check Conduit Pharmaceuticals Probability Of Bankruptcy
Conduit Pharmaceuticals Historical Income Statement
Conduit Stock Against Markets
Additional Tools for Conduit Stock Analysis
When running Conduit Pharmaceuticals' price analysis, check to measure Conduit Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Conduit Pharmaceuticals is operating at the current time. Most of Conduit Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Conduit Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Conduit Pharmaceuticals' price. Additionally, you may evaluate how the addition of Conduit Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.